CLSA analyst Elinor Leung maintains Weibo (NASDAQ:WB) with a Buy and lowers the price target from $45 to $42.7.
Abbott’s Deep Brain Stimulation Receives FDA’s Breakthrough Device Tag To Manage Depression
The FDA has granted Breakthrough Device Designation to Abbott Laboratories (NYSE:ABT) deep brain stimulation (DBS) system in treatment-resistant depression (TRD), a form…